News coverage about Tenet Healthcare (NYSE:THC) has been trending somewhat positive on Monday, Accern Sentiment reports. Accern ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Tenet Healthcare earned a media sentiment score of 0.12 on Accern’s scale. Accern also gave news coverage about the company an impact score of 46.1122884160566 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Here are some of the news articles that may have effected Accern Sentiment’s analysis:

Shares of Tenet Healthcare (NYSE:THC) opened at $13.73 on Monday. Tenet Healthcare has a one year low of $12.25 and a one year high of $22.72. The company has a current ratio of 1.28, a quick ratio of 1.21 and a debt-to-equity ratio of 21.21.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Monday, November 6th. The company reported ($0.17) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.23. Tenet Healthcare had a negative net margin of 2.85% and a negative return on equity of 5.61%. The company had revenue of $4.59 billion for the quarter, compared to the consensus estimate of $4.94 billion. During the same period last year, the company posted $0.16 EPS. The firm’s quarterly revenue was down 5.4% compared to the same quarter last year. analysts expect that Tenet Healthcare will post 0.7 EPS for the current year.

THC has been the topic of a number of analyst reports. BidaskClub downgraded shares of Tenet Healthcare from a “hold” rating to a “sell” rating in a research note on Saturday, August 5th. Jefferies Group LLC reiterated a “buy” rating and set a $24.00 price objective (down from $26.00) on shares of Tenet Healthcare in a research note on Tuesday, August 8th. Credit Suisse Group reduced their price objective on shares of Tenet Healthcare from $20.00 to $17.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 9th. Robert W. Baird reiterated an “outperform” rating and set a $23.00 price objective on shares of Tenet Healthcare in a research note on Thursday, August 10th. Finally, Citigroup Inc. reiterated a “neutral” rating and set a $16.00 price objective (down from $20.00) on shares of Tenet Healthcare in a research note on Thursday, August 10th. Two investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus target price of $19.00.

TRADEMARK VIOLATION WARNING: “Tenet Healthcare (THC) Receives Daily News Sentiment Score of 0.12” was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/tenet-healthcare-thc-receives-daily-news-sentiment-score-of-0-12/1728336.html.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company’s segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children’s hospitals, two specialty hospitals and one critical access hospital.

Insider Buying and Selling by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.